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Abstract
The objective of this study is to characterize sur-
vival in children with AIDS diagnosed in Bra-
zil between 1999-2002, compared with the first 
national study (1983-1998). This national ret-
rospective cohort study examined a representa-
tive sample of Brazilian children exposed to HIV 
from mother-to-child transmission and followed 
through 2007. The survival probability after 60 
months was analyzed by sex, year of birth and 
death, clinical classification, use of antiretrovi-
ral therapy (ART) and prophylaxis for opportu-
nistic diseases. 920 children were included. The 
survival probability increased: comparing cases 
diagnosed before 1988 with those diagnosed 
from 2001-2002 it increased by 3.5-fold (from 
25% to 86.3%). Use of ART, initial clinical classi-
fication, and final classification were significant 
(p < 0.001) predictors of survival. Issues regarding 
quality of records and care were identified. The 
results point to the success of the Brazilian policy 
of providing ART. The improvement of clinical 
status contributes to quality of life, while indicat-
ing challenges, particularly practices to improve 
long-term care.
Acquired Immunodeficiency Syndrome; Infec-
tions Disease Transmission; Survival Analysis; 
Highly Active Antiretroviral Therapy 
Introduction
In the past 10 years especially, evidence has been 
accumulated regarding reduction of morbidity 
and mortality from HIV infection in both adults 
and children 1,2,3,4,5,6,7. Even with the emergence 
of chronic diseases associated with HIV and its 
treatment 8, overall improvements have been 
clearly documented in both developing and de-
veloped countries. Brazil stands out for its sus-
tained policies to combat the epidemic 8,9,10,11,12.
To assess the impact of these actions, the 
analysis of survival times in children with AIDS 
is crucial, with various implications for both 
individuals and public health 13. In addition to 
assessing needs relating to patient care and the 
establishment of public policies, it represents a 
key outcome to assess interventions aimed at 
prolonging life 14.
In Brazil, few studies have evaluated survival 
in children with AIDS 10. The first national study 
obtained some of the first evidence regarding 
the impact of drug access on survival in children 
infected by vertical transmission in developing 
countries 14,15. Overall survival to 60 months was 
52.8% (95% confidence interval – 95%CI: 41.9-
60.8) in 914 AIDS cases reported from 1983 to 
1998 and followed to the end of June 2002. In this 
study, over time there was a significant improve-
ment in survival among Brazilian children with 
AIDS infected through vertical transmission, with 
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over 75% of cases diagnosed in 1997 and 1998 still 
living five years after diagnosis 15.
The lack of survival studies in the country, es-
pecially in the pediatric population, and changes 
in medical services and treatments since 1998 
justified a new expanded national study of sur-
vival in pediatric AIDS patients. These changes 
require ongoing monitoring of survival time, 
as does the need to evaluate the impact of in-
equality in access to preventive and treatment 
measures. 
Preliminary results of the second national 
study, which included children diagnosed with 
AIDS from 1999 to 2002, showed a continuation 
of the improving trend found in the first study, 
with a survival probability at 60 months of 86.3% 
(95%CI: 84.1-88.5) 16. It also drew attention to is-
sues like quality of health care, types of antiretro-
viral therapy and prophylaxis for opportunistic 
infections. This article aims to present a deeper 
analysis of survival in children with AIDS diag-
nosed between 1999 and 2002, exposed to HIV 
through vertical transmission and followed until 
2007. We also place these results in the context of 
the first national study.
Methodology
Study design
This is the second multicenter retrospective 
cohort survival study of Brazilian children (0 to 
12 years of age) with AIDS 16. It is characterized 
by being a historical cohort, following a similar 
methodology to the first national study (between 
1983 and 1998). This earlier study has been de-
scribed in detail previously 15; we note some 
highlights below.
Study population
A population-based study was composed of AIDS 
cases in children living in 26 states and the Fed-
eral District of Brazil. The Notifiable Diseases In-
formation System (SINAN) specific for AIDS in 
children was taken as a reference database. This 
database of the Brazilian National STD/AIDS 
Program was accessed from the Brazilian Minis-
try of Health in February 2006 and included 3,826 
AIDS cases in children diagnosed between 1999 
and 2002.
The sample size was determined to allow 
significant comparisons between proportions of 
survivors at particular times. The study sample 
was probabilistic, stratified, and selected cases in 
two stages: municipalities and individual cases. It 
was divided into four regional strata: the North-
east, Southeast, South, and a combination of the 
North and Midwest. Considering the low number 
of cases in this latter stratum there was no sam-
pling, and all cases diagnosed during the study 
period were included.
Only municipalities with more than two 
cases reported were included; 38.9% of munici-
palities had only one reported case, while 52.6% 
had two reported cases. Excluding these, 145 
remaining municipalities were responsible for 
the reporting of 3,629 cases, 94.7% of all cases 
in Brazil. The Northern Region had 120 cases in 
7 counties; the Northeast Region, 363 cases in 
16 counties; the Midwest Region, 190 cases in 6 
counties; the Southeast region, 1,964 cases in 73 
counties; and the Southern Region, 992 cases in 
43 municipalities.
Parameters for the sample size calculation 
were based on the results of the first national sur-
vival study. We assumed median survival of ap-
proximately 8.5 years and a mortality coefficient 
of 0.0815. Based on these criteria, we selected 
1,444 children (under 13) with AIDS registered in 
SINAN during the period from 01 January 1999 
to December 31, 2002. Follow up continued until 
death or the end of 2007.
Data collection
The process of data collection was continued 
until December 2007. It consisted of initial con-
tact with health services where the case had been 
treated, records location and transcription of 
available information for an abstraction form, 
based on one used in the first national study. The 
local staff of the State Program for the Control of 
STD/AIDS and of care facilities was contacted to 
explain the study and to confirm the accuracy 
of data regarding medical history and current 
status. This included health care professionals 
directly or indirectly involved with patient care, 
surveillance and/or research related to HIV/AIDS 
in children.
Additional sources of information were the 
databases of the Mortality Information System 
(SIM-DATASUS), the Drugs Logistics Manage-
ment System (SICLOM-MS) and the Laboratory 
Tests Control System (SISCEL-MS). To this end, 
we used the software Rec Link 2.0 17, following the 
methodology adopted by the Ministry of Health 
and matching on the child’s name, mother’s 
name and date of birth 18.
Data analysis
The study database was analyzed using the Sta-
tistical Package for Social Sciences (SPSS Inc., 
Chicago, USA) version 15.0. Besides descriptive 
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analysis, the survival probability at 60 months 
was calculated, with the binomial 95%CI. We 
then proceeded to the construction of survival 
curves using the Kaplan-Meier estimate of sur-
vival probability 19,20. 
Survival analysis aimed at assessing the oc-
currence of AIDS-related death as an outcome 
within a period of time that had the date of the 
case definition of AIDS in children as the starting 
date. The date of AIDS diagnosis was reassessed 
during the search using the AIDS case definition 
used in Brazil since 2004 21.
Date of death was established through the 
evaluation of medical records and/or mortality 
system data, when available. For children whose 
information about death was not known, the date 
of censure was set as the date of the last recorded 
visit to health care services.
A sensitivity analysis showed that a weighted 
analysis adjusting for different sampling prob-
ability by location would change survival esti-
mates by less than 1%. We present the unweight-
ed analysis for simplicity.
Comparisons of survival curves by sex, year 
of birth, year of diagnosis, classification (stage) 
of HIV infection (initial and current – for the sole 
purpose of comparison), use of prophylaxis for 
opportunistic diseases and antiretroviral therapy 
(used at any time) were performed using the log-
rank test or Breslow test 20,22.
Ethical considerations
The project was approved by the Research Eth-
ics Committee at the Center for Reference and 
Training in STD/AIDS of São Paulo State, under 
protocol nº. 090/2006, following the guidelines of 
the National Health Council expressed in Resolu-
tion nº. 196 of 1996.
Results
In a first step, 462 (32%) of the 1.444 cases identi-
fied were excluded for incorrect records in SINAN: 
duplication (46 = 3.2%), AIDS diagnosis outside 
the study period (66 = 4.3%), cases of HIV infec-
tion but not AIDS (4 = 0.3%) and cases of children 
exposed perinatally to HIV and uninfected (32 = 
2.2%). We excluded another 291 (20.1%) cases for 
which records could not be located during field 
work and 23 (1.6%) with loss of follow-up and 
no significant information available. Of the re-
maining total of 982 children, 945 (97.5%) were 
exposed to HIV through vertical transmission. 
The 37 remaining cases had the following forms 
of exposure to HIV: unknown/no information, 20 
(2%), transfusion of blood/components, 8 (0.9%) 
indeterminate, 6 (0.6%) and sexual, 3 (0.3%). We 
eliminated an additional 25 cases for whom the 
date of death was the same as the date of diag-
nosis and who thus had zero follow-up time for 
analysis. Thus, a total of 920 cases were included 
in analysis.
The overall probability of survival for 60 
months among these children diagnosed with 
AIDS in 1999 to 2002 was 0.883 (95%CI: 0.860-
0.902). There were 109 deaths observed (11.9%) 
and followed until the end of 2007; 78% of these 
deaths took place in the period of 1999 to 2002.
Figure 1 presents an integrated survival curve 
of the two national studies, according to different 
periods of AIDS diagnosis, showing the sustained 
gain in survival of these children.
In the first national study, considering the 
whole period from 1983 to 1998, the overall sur-
vival probability at 60 months was 0.528 (95%CI: 
0.419-0.608): before 1988, 0.197 (95%CI: 0.112-
0.300); from 1988 to 1992, 0.273 (95%CI: 0.229-
0.319); from 1993 to 1994, 0.397 (95%CI: 0.334-
0.459); from 1995 to 1996, 0.595 (95%CI: 0.528-
0.656); and from 1997 to 1998, 0,682 (95%CI: 
0.616-0.739). In this present study, the survival 
probability was 0.865 (95%CI: 0.830-0.893) from 
1999 to 2000 (470 children), and 0.902 (95%CI: 
0.870-0.927) from 2001 to 2002 (450 children).
Demographic, epidemiological and clini-
cal characteristics of the 920 studied cases are 
presented in Table 1. There is a slight predomi-
nance of girls (51.7%) as well as children born in 
the 1995-1998 cohort (47.3%). In terms of year of 
AIDS diagnosis, there is a homogeneous distri-
bution in the four years of study. Regarding ini-
tial clinical classification of HIV infection, 65.4% 
were classified as B (B1, B2 and B3) or C (C1, C2 or 
C3). In the final clinical classification, these two 
categories made up 40%.
Of note is the frequency of missing data for 
some of these variables investigated in health 
services, such as: prophylaxis administration 
(23.1%), current or final clinical classification 
(3.7%), and initial clinical classification (1.9%).
Figures 2 and 3 show the survival curves by 
initial and current/final clinical classification and 
survival curves by use of antiretroviral therapy 
(ART) and prophylaxis for opportunistic infec-
tions, respectively.
Discussion
This second national study of AIDS survival in 
children confirms the strengthening of positive 
trends observed in the first study 14 and shows 
the continuing increase in survival probability. 
The survival rate over the period improved sig-
Matida LH et al. S96
Cad. Saúde Pública, Rio de Janeiro, 27 Sup 1:S93-S103, 2011
Figure 1
Survival probability after AIDS diagnosis in two national studies (1983-1998 and 1999-2002), by year of AIDS diagnosis, Brazil.
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nificantly and consistently in Brazilian children 
with AIDS 16, a fact mirrored by other studies in 
different settings around the world 7,10,14,23,24,25.
The probability of survival at 60 months rose 
from 25% before 1988 to 88% in 2001-2002, rep-
resenting a 3.5-fold increase. Compared to the 
first national study, this study showed an overall 
improvement of about 36% in this probability.
These improved results were largely made 
possible by the development of a program of uni-
versal access to ART. In this study, 94.8% of chil-
dren had received this treatment, with records of 
information of use or nonuse in 100% of cases. 
The survival probability at 60 months in children 
with recorded use of HAART (highly active anti-
retroviral therapy) was significantly (p < 0.001) 
higher compared to those without.
In fact, the period from 1999 to 2002 repre-
sents a period of greater consistency in the use of 
HAART in the country, initially adopted in 1996. 
This is the result of the actions and health poli-
cies aimed at improving access and quality of HIV 
care 14, a cost-effective initiative with significant 
impact on public health 26. In this study, the vast 
majority of children (85.1%) were born in a period 
of expanded ART availability. The higher survival 
rate observed in the cohort of children born in 
the period 1995-1998 (0.909; 95%CI: 0.878-0.933) 
compared to 1999-2002 (0.855; 95%CI: 0.813-
0.889), was not statistically significant and may 
be associated with different ages of children at 
the time of diagnosis.
Moreover, greater access to early diagnosis 
and management of HIV infection and opportu-
nistic diseases 10,11 might have contributed to the 
continuing increase in survival, similar to that 
observed in developed market economies 3,8. In 
this study, no significant difference was found 
between having or not having used prophylaxis 
in the analysis of survival at 60 months. Only 
76.9% of children had documentation about pro-
phylaxis use for infections/opportunistic infec-
tions, pointing to the need for discussion about 
the importance of both the accuracy and the 
SURVIVAL IN CHILDREN WITH AIDS S97
Cad. Saúde Pública, Rio de Janeiro, 27 Sup 1:S93-S103, 2011
completeness of medical records. Given the high 
survival rate of children in this group, there was 
likely underreporting of this variable.
The implementation of the prevention of HIV 
transmission from mother to infant and early use 
of HAART are factors that delay the progression 
of the disease, demonstrated in the increase in 
average age of AIDS diagnosis 8.
Despite the steadily increasing proportion of 
women with AIDS over the past ten years 27 and 
the likelihood of pregnancy in this population, the 
number of exposed children infected has been 
systematically reduced in Brazil 17,18,28,29. This re-
duction reflects the implementation of actions to 
reduce vertical transmission of HIV throughout 
the country, despite different patterns of perfor-
mance across regions due to operational, social 
and economic issues 10,30.
The measures adopted by various health 
services generated a pattern of improvement in 
clinical status of children. The results reinforce 
the relationship between clinical classification 
and probability of survival at 60 months, consid-
ering the initial classification and the current/
final classification, used here only for compari-
son. At first, 32.7% of children were classified as N 
Table 1
Demographic, epidemiologic and clinical characteristics, and survival probability at 60 months – 920 AIDS cases by vertical transmission. Brazil, 1999-2002.
 Variables n % Survival probability at p-value
     60 months (95%CI)
 Total 920 100.0 0.883 (0.860-0.902) -
 Sex    
  Male 444 48.3 0.877 (0.842-0.905) 
  Female 476 51.7 0.893 (0.860-0.919) 0.262
 Year of birth    
  1986-1990 25 2.7 0.758 (0.538-0.883) 
  1991-1994 112 12.2 0.892 (0.817-0.937) 
  1995-1998 435 47.3 0.909 (0.878-0.933) 
  1999-2002 348 37.8 0.855 (0.813-0.889) 0.426
 Year of AIDS diagnosis    
  1999 249 27.1 0.890 (0.844-0.923) 
  2000 221 24.0 0.836 (0.780-0.879) 
  2001 220 23.9 0.880 (0.829-0.917) 
  2002 230 25.0 0.924 (0.880-0.952) 0.216
 Initial clinical classification    
  N, N1, N2 and N3 57 6.2 0.965 (0.867-0.991) 
  A, A1, A2 and A3 244 26.5 0.983 (0.954-0.994) 
  B, B1, B2 and B3 288 31.3 0.929 (0.892-0.954) 
  C, C1, C2 and C3 314 34.1 0.755 (0.703-0.799) < 0.001
  Missing 17 1.9 - 
 Current/final clinical classification    
  N, N1, N2 and N3 193 21.0 0.995 (0.964-0,999) 
  A, A1, A2 and A3 325 35.3 0.994 (0.976-0,999) 
  B, B1, B2 and B3 188 20.4 0.947 (0.903-0.971) 
  C, C1, C2 and C3 180 19.6 0.504 (0.427-0.575) < 0.001
  Missing 34 3.7 - 
 Opportunistic infection prophylaxis    
  Yes  658 71.5 0.885 (0.857-0.907) 
  No 50 5.4 0.785 (0.635-0.897) 
  Missing 212 23.1 0.900 (0.850-0.933) 0.438
 Use of HAART    
  Yes 872 94.8 0.904 (0.882-0.922) 
  No 48 5.2 0.492 (0.343-0.624) < 0.001
HAART: highly active antiretroviral therapy.
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Figure 2
Survival probability after AIDS diagnosis in 920 cases of vertical transmission by initial and current/fi nal clinical classifi cation, Brazil.
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Figure 3
Survival probability after AIDS diagnosis in 920 cases of vertical transmission by use of antiretroviral therapy and prophylaxis for opportunistic infections, Brazil.
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or A; by the current/final evaluation, 56.3% were 
documented to have this classification (Table 1), 
despite some missing information. In this study, 
we chose to consider the evolving pattern of clas-
sification only for comparative purposes.
Other variables were not identified as be-
ing significant in the survival probability at 60 
months, such as sex, year of birth and year of 
AIDS diagnosis. Regarding gender, different 
studies reinforce these results. Regarding year of 
birth or AIDS diagnosis, the relatively short pe-
riod studied and the lack of significant changes 
in management probably account for the lack of 
difference in terms of survival probability.
The results presented in this analysis (920 
cases) are slightly different from those (86.3%, 
95%CI: 84.1-88.5) in a previously published pre-
liminary analysis in which all cases (945 cases) 
had been included 16. In the present analysis, the 
elimination of cases for whom the date of death 
was the same as the date of diagnosis and who 
thus had zero follow-up time for analysis im-
proved the accuracy of the analysis. 
Regarding limitations, one third of potential 
cases had to be excluded because of poor quality 
in the original database (SINAN) and in records 
in treatment services. These difficulties reinforce 
the need to document the care process and im-
prove epidemiological surveillance. While these 
factors may have affected the estimate of surviv-
al, they would not explain the observed increase 
in survival, unless the magnitude of any bias had 
increased substantially over time. The finding 
of duplication and inconsistencies (children ex-
posed to HIV but listed as uninfected, and those 
infected but listed as being without AIDS, for 
example) in the SINAN database reinforce this 
need. Despite these areas of improvement, the 
use of this database has the advantage of being 
representative of the Brazilian population.
Because cases are not officially reported until 
the criteria for AIDS are defined, it is only pos-
sible to construct survival estimates from this 
point, which is a limitation in the interpretation 
of data. Children diagnosed with HIV infection 
but without AIDS diagnosis were not included in 
the study. Thus, the degree of improvement and 
current levels of survival achieved are difficult to 
compare with international data from elsewhere. 
Most publications that examine the survival time 
of AIDS cases infected through vertical transmis-
sion are based on cohorts of HIV-infected chil-
dren identified at birth or soon after. The survival 
time is usually calculated from birth or date of 
HIV infection rather than the date of AIDS diag-
nosis as evaluated in this study.
Differences in survival by region should also 
be taken into account when comparing survival 
results by regions of the country. Compared to 
the first national study, any such difference prob-
ably was less important considering that since 
1999 various initiatives were undertaken nation-
ally in Brazil including HIV testing for the general 
population, improvement of prenatal screening, 
and follow-up of pregnant women and HIV ex-
posed children.
Problems with the quality and access to med-
ical records of cases in terms of file organization 
were observed in some services. This includes 
limitations of available data for epidemiological 
factors (issues relating to mother and family in 
general, diagnosis knowledge by the child, care-
giver, and others) and clinical factors (record of 
important dates related to clinical events or the 
therapies adopted, transfers, current situation of 
children, among others).
Another factor apparent in a nationwide 
study of this magnitude is the difficulty in follow-
ing the evolution of individual cases. This is due 
to changes in the site of medical care of children 
after reporting (different from the listed site in the 
SINAN data base), and poorly or undocumented 
clinic attendance.
The scenario for the future efforts to address 
AIDS in children presents a number of challeng-
es related not only to the pathogenesis of HIV in-
fection in this population 31, but also in relation 
to the management of children exposed to HIV 
over these years 32,33,34. Analysis of the Brazil-
ian experience shows that in a country with lim-
ited resources, and large geographical and social 
inequalities, it is possible to establish a system 
capable of providing free and universal access 
to HAART and diagnosis of HIV infection 17,35. 
Many low and middle income countries still 
have similar survival results to Brazil in the pre-
HAART era, despite the advances achieved 24,36. 
The Brazilian findings demonstrate the practi-
cal possibilities of dealing with this problem in 
these countries.
Despite clear advances, as the results show, 
there is a need to enhance the implementation of 
technical and organizational recommendations 
for the Brazilian National STD/AIDS Program. 
The challenge is to extend improvements not 
only in the quantity but also the quality of health 
care 14. This reinforces the need for future pop-
ulation-based and in-depth studies incorporat-
ing data that reflect the performance of different 
areas of the country. Survival studies are essen-
tial for the evaluation of intervention strategies 
aimed at prolonging the life of these patients, and 
can help inform the needs for clinical care and 
the establishment of public policies 15.
The Unified National Health System faces 
new challenges. One is the presence of adoles-
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cents and adults infected through their mothers, 
which increases the need for a longitudinal and 
a holistic approach involving not only biological, 
but also psychological and social aspects.
In conclusion, the results of the second na-
tional study point to the successes of Brazilian 
policies in addressing AIDS among children, with 
a significant and sustained increase in the sur-
vival probability over several years, due in large 
part to the use of HAART. The improvement in 
clinical status is a reflection of these results and 
is probably accompanied by a similar improve-
ment in quality of life of these children. These 
data demonstrate the feasibility of incorporating 
these strategies, even in a country with great so-
cial inequalities.
Resumo
Este estudo caracteriza a sobrevida em crianças com 
AIDS no Brasil entre 1999-2002, contextualizando 
com o primeiro estudo nacional (1983-1998). Trata-se 
de coorte histórica, com crianças expostas ao HIV por 
transmissão vertical e acompanhadas até 2007. A pro-
babilidade de sobrevivência em 60 meses foi analisada 
segundo sexo, ano de nascimento e de óbito, classifi-
cação clínica, uso de terapia antirretroviral (TARV) e 
de profilaxia para doenças oportunistas. No total, 920 
crianças foram incluídas. A probabilidade de sobrevi-
vência foi ampliada 3,5 vezes nos dois períodos ava-
liados, passando de 25% antes de 1988 para 86,3% no 
período de 2001-2002. Uso de TARV, classificação clíni-
ca inicial e atual/final foram preditores que influíram 
significativamente (p < 0,001) para a ampliação da so-
brevida. Os resultados deste estudo indicam o sucesso 
da política brasileira para a abordagem das crianças 
infectadas com HIV. A melhora do estado clínico con-
tribuiu para melhora da qualidade de vida, mas sina-
liza-se para a necessidade de incorporação de práticas 
pautadas na integralidade do cuidado.
Síndrome de Imunodeficiência Adquirida; Transmis-
são Vertical de Doença Infecciosa; Análise de Sobrevi-
da; Terapia Anti-Retroviral de Alta Atividade
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